These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 10928470

  • 1. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Fujita M, Izutani W, Komurasaki Y.
    Thromb Haemost; 2000 Jul; 84(1):54-8. PubMed ID: 10928470
    [Abstract] [Full Text] [Related]

  • 2. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
    Izutani W, Fujita M, Nishizawa K, Koga J.
    Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
    [Abstract] [Full Text] [Related]

  • 3. The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats.
    Yun-Choi HS, Pyo MK, Chang KC, Lee DH.
    Planta Med; 2002 Apr; 68(4):326-9. PubMed ID: 11988856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of two tetrahydroisoquinolines (YS-49 and YS-51) on experimental disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Pyo MK, Yun-Choi HS, Chang KC, Lee DH.
    Arzneimittelforschung; 2004 Apr; 54(11):705-10. PubMed ID: 15612611
    [Abstract] [Full Text] [Related]

  • 6. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y, Ota M, Katsuura Y, Komoriya K, Nakagaki T.
    Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T, Furukawa Y, Murakami M, Watanabe K, Kondo M.
    Thromb Haemost; 1982 Oct 29; 48(2):235-7. PubMed ID: 7179203
    [Abstract] [Full Text] [Related]

  • 10. 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation.
    Tunali T, Yarat A, Bulut M, Emekli N.
    Br J Haematol; 2004 Jul 29; 126(2):226-30. PubMed ID: 15238144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
    Yamazaki M, Asakura H, Aoshima K, Saito M, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Ikeda T, Matsuda T.
    Semin Thromb Hemost; 1996 Jul 29; 22(3):255-9. PubMed ID: 8836010
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T, Murakami M, Furukawa Y, Takemura S, Kondo M.
    Thromb Haemost; 1983 Jun 28; 49(3):190-2. PubMed ID: 6879507
    [Abstract] [Full Text] [Related]

  • 15. Novel recombinant fibrinogenase of Agkistrodon acutus venom protects against LPS-induced DIC.
    Wang R, Cai J, Huang Y, Xu D, Sang H, Yan G.
    Thromb Res; 2009 Apr 28; 123(6):919-24. PubMed ID: 19070354
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia.
    Chen HW, Kuo HT, Chai CY, Ou JL, Yang RC.
    J Endotoxin Res; 2007 Apr 28; 13(1):15-23. PubMed ID: 17621542
    [Abstract] [Full Text] [Related]

  • 17. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ, Owen CA.
    Southeast Asian J Trop Med Public Health; 1979 Sep 28; 10(3):325-7. PubMed ID: 515796
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S.
    Thromb Haemost; 1994 Apr 28; 71(4):452-5. PubMed ID: 8052962
    [Abstract] [Full Text] [Related]

  • 19. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
    Takahashi Y, Hosaka Y, Imada K, Adachi T, Niina H, Watanabe M, Mochizuki H.
    Thromb Haemost; 1997 Apr 28; 77(4):789-95. PubMed ID: 9134660
    [Abstract] [Full Text] [Related]

  • 20. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H, Takahashi Y, Kubo A, Ontachi Y, Hayashi T, Omote M, Arahata M, Kadohira Y, Maekawa M, Yamazaki M, Morishita E, Takami A, Yoshida T, Miyamoto K, Nakao S.
    Crit Care Med; 2006 Sep 28; 34(9):2421-5. PubMed ID: 16810104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.